We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

EN
  • 01.png
NMPA Registration No. 20253401057

Respiratory Bacterial Pathogen Multiplex Nucleic Acid Detection Kit (Fluorescent PCR Method)

  • Multiple Panels for Precise Stratification

    Innovative “1+2” panel portfolio covering six major core pathogens; accurately differentiates community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) scenarios to meet the differentiated diagnostic needs of various clinical departments.

  • Rapid and Highly Sensitive Detection

    Reports available within 1 hour, with sensitivity up to 500 copies/mL; overcomes the limitations of time-consuming traditional culture and difficult detection of fastidious bacteria, helping secure the critical treatment window for emergency and critically ill patients.

  • Pathogen Identification for Rational Medication

    Enables early identification of causative pathogens, including key drug-resistant Gram-positive bacteria, providing evidence for de-escalation and targeted therapy; reduces empirical antibiotic overuse and supports antimicrobial stewardship (AMS).

image.png